Anti-SMYD3 monoclonal antibody

Pre-made anti-SMYD3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SMYD3/SMYD3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T35792-Ab-1/ GM-Tg-hg-T35792-Ab-2Anti-Human SMYD3 monoclonal antibodyHuman
GM-Tg-rg-T35792-Ab-1/ GM-Tg-rg-T35792-Ab-2Anti-Rat SMYD3 monoclonal antibodyRat
GM-Tg-mg-T35792-Ab-1/ GM-Tg-mg-T35792-Ab-2Anti-Mouse SMYD3 monoclonal antibodyMouse
GM-Tg-cynog-T35792-Ab-1/ GM-Tg-cynog-T35792-Ab-2Anti-Cynomolgus/ Rhesus macaque SMYD3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T35792-Ab-1/ GM-Tg-felg-T35792-Ab-2Anti-Feline SMYD3 monoclonal antibodyFeline
GM-Tg-cang-T35792-Ab-1/ GM-Tg-cang-T35792-Ab-2Anti-Canine SMYD3 monoclonal antibodyCanine
GM-Tg-bovg-T35792-Ab-1/ GM-Tg-bovg-T35792-Ab-2Anti-Bovine SMYD3 monoclonal antibodyBovine
GM-Tg-equg-T35792-Ab-1/ GM-Tg-equg-T35792-Ab-2Anti-Equine SMYD3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T35792-Ab-1/ GM-Tg-hg-T35792-Ab-2; GM-Tg-rg-T35792-Ab-1/ GM-Tg-rg-T35792-Ab-2;
GM-Tg-mg-T35792-Ab-1/ GM-Tg-mg-T35792-Ab-2; GM-Tg-cynog-T35792-Ab-1/ GM-Tg-cynog-T35792-Ab-2;
GM-Tg-felg-T35792-Ab-1/ GM-Tg-felg-T35792-Ab-2; GM-Tg-cang-T35792-Ab-1/ GM-Tg-cang-T35792-Ab-2;
GM-Tg-bovg-T35792-Ab-1/ GM-Tg-bovg-T35792-Ab-2; GM-Tg-equg-T35792-Ab-1/ GM-Tg-equg-T35792-Ab-2
Products NameAnti-SMYD3 monoclonal antibody
Formatmab
Target NameSMYD3
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SMYD3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T35792-Ag-1Recombinant multi-species SMYD3/ KMT3E/ ZMYND1 protein
    ORF Viral VectorpGMLP002007human SMYD3 Lentivirus plasmid
    ORF Viral VectorvGMLP002007human SMYD3 Lentivirus particle
    ORF Viral VectorpGMLPm002645mouse Smyd3 Lentivirus plasmid
    ORF Viral VectorvGMLPm002645mouse Smyd3 Lentivirus particle


    Target information

    Target IDGM-T35792
    Target NameSMYD3
    Gene ID64754,69726,498295,703402,480101,101089231,616050,100059267
    Gene Symbol and Synonyms2410008A19Rik,bA74P14.1,KMT3E,SMYD3,ZMYND1,ZNFN3A1
    Uniprot AccessionQ9H7B4
    Uniprot Entry NameSMYD3_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000185420
    Target ClassificationN/A

    The target: SMYD3, gene name: SMYD3, also named as KMT3E, ZMYND1, ZNFN3A1, bA74P14.1. This gene encodes a histone methyltransferase which functions in RNA polymerase II complexes by an interaction with a specific RNA helicase. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.